Taiwan FDA registration 76ff3dcbe23345fb5838bf29fd1ea888
RAMP Procalcitonin
TW: “倫普”降鈣素原檢驗試劑組
Taiwan·Risk Class 2·MD·RESPONSE BIOMEDICAL CORPORATION·Registered Jul 05, 2018 – Jul 05, 2028ActiveRegistration details
- Analysis ID
- 76ff3dcbe23345fb5838bf29fd1ea888
- License Form
- Ministry of Health Medical Device Import No. 031314
- Customs Code
- DHA05603131402
Company information
- Manufacturer
- RESPONSE BIOMEDICAL CORPORATION
- Manufacturer Country
- Canada
- Authorized Representative
- RECHI CO., LTD.
Product details
- Intended Use
- This product is used with RAMP instrument to quantitatively detect the content of procalcitonin in EDTA whole blood in vitro by immunochromocytometry.
- Product Type (Level 1)
- C Immunology and microbiology devices
- Product Type (Level 2)
- C3210 Endotoxin Analysis Reagent
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jul 05, 2018
- Expiry Date
- Jul 05, 2028
About this record
Access comprehensive regulatory information for RAMP Procalcitonin in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 76ff3dcbe23345fb5838bf29fd1ea888 and manufactured by RESPONSE BIOMEDICAL CORPORATION. The authorized representative in Taiwan is RECHI CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices